 | • レポートコード：QYR2104Z1819 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、糖尿病管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（モニタリング装置、診断装置、インスリン送達装置、その他装置）、用途別市場規模（病院、家庭）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・糖尿病管理の市場動向 ・企業の競争状況、市場シェア ・糖尿病管理の種類別市場規模（モニタリング装置、診断装置、インスリン送達装置、その他装置） ・糖尿病管理の用途別市場規模（病院、家庭） ・糖尿病管理の北米市場規模2016-2027（アメリカ、カナダ） ・糖尿病管理のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・糖尿病管理のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・糖尿病管理の中南米市場規模2016-2027（メキシコ、ブラジル） ・糖尿病管理の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Bayer、Bristol-Myers Squibb、Eli Lilly、Sanofi、Dexcom、Medtronic、Novo Nordisk） ・結論 |
Diabetes, scientifically known as diabetes mellitus, is a clinical condition where person has an elevated blood glucose level.
It occurs due to either inefficiency of pancreases to produce insulin (Type I) or unresponsiveness of body cells to the produced insulin (Type II) or both. This condition specifically results in polyuria, increase in thrust and hunger. This condition specifically results in polyuria, increase in thrust and hunger.
Market Analysis and Insights: Global Diabetes Management Market
The global Diabetes Management market size is projected to reach US$ 13150 million by 2026, from US$ 5369 million in 2019, at a CAGR of 13.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Management market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Management market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Management market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Management market.
Global Diabetes Management Scope and Market Size
Diabetes Management market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Management market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Monitoring Devices
Diagnostic Devices
Insulin Delivery Devices
Other Devices
Segment by Application
Hospital
home
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Bayer
Bristol-Myers Squibb
Eli Lilly
Sanofi
Dexcom
Medtronic
Novo Nordisk
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Management Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monitoring Devices
1.2.3 Diagnostic Devices
1.2.4 Insulin Delivery Devices
1.2.5 Other Devices
1.3 Market by Application
1.3.1 Global Diabetes Management Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 home
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Management Market Perspective (2016-2027)
2.2 Diabetes Management Growth Trends by Regions
2.2.1 Diabetes Management Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetes Management Historic Market Share by Regions (2016-2021)
2.2.3 Diabetes Management Forecasted Market Size by Regions (2022-2027)
2.3 Diabetes Management Industry Dynamic
2.3.1 Diabetes Management Market Trends
2.3.2 Diabetes Management Market Drivers
2.3.3 Diabetes Management Market Challenges
2.3.4 Diabetes Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Management Players by Revenue
3.1.1 Global Top Diabetes Management Players by Revenue (2016-2021)
3.1.2 Global Diabetes Management Revenue Market Share by Players (2016-2021)
3.2 Global Diabetes Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetes Management Revenue
3.4 Global Diabetes Management Market Concentration Ratio
3.4.1 Global Diabetes Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Management Revenue in 2020
3.5 Diabetes Management Key Players Head office and Area Served
3.6 Key Players Diabetes Management Product Solution and Service
3.7 Date of Enter into Diabetes Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Management Breakdown Data by Type
4.1 Global Diabetes Management Historic Market Size by Type (2016-2021)
4.2 Global Diabetes Management Forecasted Market Size by Type (2022-2027)
5 Diabetes Management Breakdown Data by Application
5.1 Global Diabetes Management Historic Market Size by Application (2016-2021)
5.2 Global Diabetes Management Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Diabetes Management Market Size (2016-2027)
6.2 North America Diabetes Management Market Size by Type
6.2.1 North America Diabetes Management Market Size by Type (2016-2021)
6.2.2 North America Diabetes Management Market Size by Type (2022-2027)
6.2.3 North America Diabetes Management Market Size by Type (2016-2027)
6.3 North America Diabetes Management Market Size by Application
6.3.1 North America Diabetes Management Market Size by Application (2016-2021)
6.3.2 North America Diabetes Management Market Size by Application (2022-2027)
6.3.3 North America Diabetes Management Market Size by Application (2016-2027)
6.4 North America Diabetes Management Market Size by Country
6.4.1 North America Diabetes Management Market Size by Country (2016-2021)
6.4.2 North America Diabetes Management Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Diabetes Management Market Size (2016-2027)
7.2 Europe Diabetes Management Market Size by Type
7.2.1 Europe Diabetes Management Market Size by Type (2016-2021)
7.2.2 Europe Diabetes Management Market Size by Type (2022-2027)
7.2.3 Europe Diabetes Management Market Size by Type (2016-2027)
7.3 Europe Diabetes Management Market Size by Application
7.3.1 Europe Diabetes Management Market Size by Application (2016-2021)
7.3.2 Europe Diabetes Management Market Size by Application (2022-2027)
7.3.3 Europe Diabetes Management Market Size by Application (2016-2027)
7.4 Europe Diabetes Management Market Size by Country
7.4.1 Europe Diabetes Management Market Size by Country (2016-2021)
7.4.2 Europe Diabetes Management Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Management Market Size (2016-2027)
8.2 Asia-Pacific Diabetes Management Market Size by Type
8.2.1 Asia-Pacific Diabetes Management Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetes Management Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetes Management Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetes Management Market Size by Application
8.3.1 Asia-Pacific Diabetes Management Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetes Management Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetes Management Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetes Management Market Size by Region
8.4.1 Asia-Pacific Diabetes Management Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetes Management Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetes Management Market Size (2016-2027)
9.2 Latin America Diabetes Management Market Size by Type
9.2.1 Latin America Diabetes Management Market Size by Type (2016-2021)
9.2.2 Latin America Diabetes Management Market Size by Type (2022-2027)
9.2.3 Latin America Diabetes Management Market Size by Type (2016-2027)
9.3 Latin America Diabetes Management Market Size by Application
9.3.1 Latin America Diabetes Management Market Size by Application (2016-2021)
9.3.2 Latin America Diabetes Management Market Size by Application (2022-2027)
9.3.3 Latin America Diabetes Management Market Size by Application (2016-2027)
9.4 Latin America Diabetes Management Market Size by Country
9.4.1 Latin America Diabetes Management Market Size by Country (2016-2021)
9.4.2 Latin America Diabetes Management Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Management Market Size (2016-2027)
10.2 Middle East & Africa Diabetes Management Market Size by Type
10.2.1 Middle East & Africa Diabetes Management Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetes Management Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetes Management Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetes Management Market Size by Application
10.3.1 Middle East & Africa Diabetes Management Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetes Management Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetes Management Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetes Management Market Size by Country
10.4.1 Middle East & Africa Diabetes Management Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetes Management Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Diabetes Management Introduction
11.1.4 Abbott Revenue in Diabetes Management Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Diabetes Management Introduction
11.2.4 Bayer Revenue in Diabetes Management Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Diabetes Management Introduction
11.3.4 Bristol-Myers Squibb Revenue in Diabetes Management Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Diabetes Management Introduction
11.4.4 Eli Lilly Revenue in Diabetes Management Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Diabetes Management Introduction
11.5.4 Sanofi Revenue in Diabetes Management Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Dexcom
11.6.1 Dexcom Company Details
11.6.2 Dexcom Business Overview
11.6.3 Dexcom Diabetes Management Introduction
11.6.4 Dexcom Revenue in Diabetes Management Business (2016-2021)
11.6.5 Dexcom Recent Development
11.7 Medtronic
11.7.1 Medtronic Company Details
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Diabetes Management Introduction
11.7.4 Medtronic Revenue in Diabetes Management Business (2016-2021)
11.7.5 Medtronic Recent Development
11.8 Novo Nordisk
11.8.1 Novo Nordisk Company Details
11.8.2 Novo Nordisk Business Overview
11.8.3 Novo Nordisk Diabetes Management Introduction
11.8.4 Novo Nordisk Revenue in Diabetes Management Business (2016-2021)
11.8.5 Novo Nordisk Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Diabetes Management Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monitoring Devices
Table 3. Key Players of Diagnostic Devices
Table 4. Key Players of Insulin Delivery Devices
Table 5. Key Players of Other Devices
Table 6. Global Diabetes Management Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Diabetes Management Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Diabetes Management Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Diabetes Management Market Share by Regions (2016-2021)
Table 10. Global Diabetes Management Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Diabetes Management Market Share by Regions (2022-2027)
Table 12. Diabetes Management Market Trends
Table 13. Diabetes Management Market Drivers
Table 14. Diabetes Management Market Challenges
Table 15. Diabetes Management Market Restraints
Table 16. Global Diabetes Management Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Diabetes Management Market Share by Players (2016-2021)
Table 18. Global Top Diabetes Management Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Management as of 2020)
Table 19. Ranking of Global Top Diabetes Management Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Diabetes Management Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Diabetes Management Product Solution and Service
Table 23. Date of Enter into Diabetes Management Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Diabetes Management Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Diabetes Management Revenue Market Share by Type (2016-2021)
Table 27. Global Diabetes Management Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Diabetes Management Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Diabetes Management Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Diabetes Management Revenue Market Share by Application (2016-2021)
Table 31. Global Diabetes Management Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Diabetes Management Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Diabetes Management Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Diabetes Management Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Diabetes Management Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Diabetes Management Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Diabetes Management Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Diabetes Management Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Diabetes Management Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Diabetes Management Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Diabetes Management Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Diabetes Management Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Diabetes Management Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Diabetes Management Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Diabetes Management Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Diabetes Management Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Diabetes Management Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Diabetes Management Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Diabetes Management Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Diabetes Management Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Diabetes Management Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Diabetes Management Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Diabetes Management Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Diabetes Management Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Diabetes Management Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Diabetes Management Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Diabetes Management Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Diabetes Management Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Diabetes Management Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Diabetes Management Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Diabetes Management Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Diabetes Management Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Diabetes Management Product
Table 66. Abbott Revenue in Diabetes Management Business (2016-2021) & (US$ Million)
Table 67. Abbott Recent Development
Table 68. Bayer Company Details
Table 69. Bayer Business Overview
Table 70. Bayer Diabetes Management Product
Table 71. Bayer Revenue in Diabetes Management Business (2016-2021) & (US$ Million)
Table 72. Bayer Recent Development
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Diabetes Management Product
Table 76. Bristol-Myers Squibb Revenue in Diabetes Management Business (2016-2021) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Eli Lilly Company Details
Table 79. Eli Lilly Business Overview
Table 80. Eli Lilly Diabetes Management Product
Table 81. Eli Lilly Revenue in Diabetes Management Business (2016-2021) & (US$ Million)
Table 82. Eli Lilly Recent Development
Table 83. Sanofi Company Details
Table 84. Sanofi Business Overview
Table 85. Sanofi Diabetes Management Product
Table 86. Sanofi Revenue in Diabetes Management Business (2016-2021) & (US$ Million)
Table 87. Sanofi Recent Development
Table 88. Dexcom Company Details
Table 89. Dexcom Business Overview
Table 90. Dexcom Diabetes Management Product
Table 91. Dexcom Revenue in Diabetes Management Business (2016-2021) & (US$ Million)
Table 92. Dexcom Recent Development
Table 93. Medtronic Company Details
Table 94. Medtronic Business Overview
Table 95. Medtronic Diabetes Management Product
Table 96. Medtronic Revenue in Diabetes Management Business (2016-2021) & (US$ Million)
Table 97. Medtronic Recent Development
Table 98. Novo Nordisk Company Details
Table 99. Novo Nordisk Business Overview
Table 100. Novo Nordisk Revenue in Diabetes Management Business (2016-2021) & (US$ Million)
Table 101. Novo Nordisk Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Management Market Share by Type: 2020 VS 2027
Figure 2. Monitoring Devices Features
Figure 3. Diagnostic Devices Features
Figure 4. Insulin Delivery Devices Features
Figure 5. Other Devices Features
Figure 6. Global Diabetes Management Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. home Case Studies
Figure 9. Diabetes Management Report Years Considered
Figure 10. Global Diabetes Management Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Diabetes Management Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Diabetes Management Market Share by Regions: 2020 VS 2027
Figure 13. Global Diabetes Management Market Share by Regions (2022-2027)
Figure 14. Global Diabetes Management Market Share by Players in 2020
Figure 15. Global Top Diabetes Management Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Management as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Diabetes Management Revenue in 2020
Figure 17. Global Diabetes Management Revenue Market Share by Type (2016-2021)
Figure 18. Global Diabetes Management Revenue Market Share by Type (2022-2027)
Figure 19. North America Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Diabetes Management Market Share by Type (2016-2027)
Figure 21. North America Diabetes Management Market Share by Application (2016-2027)
Figure 22. North America Diabetes Management Market Share by Country (2016-2027)
Figure 23. United States Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Diabetes Management Market Share by Type (2016-2027)
Figure 27. Europe Diabetes Management Market Share by Application (2016-2027)
Figure 28. Europe Diabetes Management Market Share by Country (2016-2027)
Figure 29. Germany Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Diabetes Management Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Diabetes Management Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Diabetes Management Market Share by Region (2016-2027)
Figure 39. China Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Diabetes Management Market Share by Type (2016-2027)
Figure 47. Latin America Diabetes Management Market Share by Application (2016-2027)
Figure 48. Latin America Diabetes Management Market Share by Country (2016-2027)
Figure 49. Mexico Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Diabetes Management Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Diabetes Management Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Diabetes Management Market Share by Country (2016-2027)
Figure 55. Turkey Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Diabetes Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Abbott Revenue Growth Rate in Diabetes Management Business (2016-2021)
Figure 59. Bayer Revenue Growth Rate in Diabetes Management Business (2016-2021)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Diabetes Management Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Diabetes Management Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Diabetes Management Business (2016-2021)
Figure 63. Dexcom Revenue Growth Rate in Diabetes Management Business (2016-2021)
Figure 64. Medtronic Revenue Growth Rate in Diabetes Management Business (2016-2021)
Figure 65. Novo Nordisk Revenue Growth Rate in Diabetes Management Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の糖尿病管理装置市場規模・現状・予測（2021年-2027年） Diabetes management devices include insulin delivery systems and blood glucose monitoring devices, which are used to treat diabetes effectively and efficiently with fewer side effects. Diabetes (type 1 and type 2) is a chronic disease condition, which occurs due to glucose impairment. The major fact…- 世界の糖尿病管理における人工知能（AI）市場規模・現状・予測（2021年-2027年） Artificial Intelligence in diabetes management is an automotion system which employs a computer system that gathers data, understands, reasons, and learns how the information effects outcomes over time.That the system ingests massive amounts of information—both structured and unstructured data—such …
- 世界の糖尿病管理における人工知能（AI）市場規模・現状・予測（2021年-2027年） Artificial Intelligence in diabetes management is an automotion system which employs a computer system that gathers data, understands, reasons, and learns how the information effects outcomes over time.That the system ingests massive amounts of information—both structured and unstructured data—such …
- 世界の糖尿病治療装置・薬剤市場規模・現状・予測（2021年-2027年） Diabetes Care Devices & Drugs is used to treat diabetes equipment and drugs. The global diabetes care devices & drugs market is mainly driven by thereasingidence & prevalence of diabetes, technological advancements, rising obesity rate, andreasingdentary lifestyle & improper diet. Market Analysis an…
- 世界の糖尿病管理製品市場規模・現状・予測（2021年-2027年） Diabetes Management Products are designed to restore carbohydrate metabolism to a normal state as much as possible through treatment or prevention. Market Analysis and Insights: Global Diabetes Management Products Market The global Diabetes Management Products market size is projected to reach US$ X…